SUBJECTS : Immunology | Immune System | Immune-based Therap
ImmunoTargets and Therapy: 2021, vol: 10, issue:
- 1)- Jessica D Macdougall, A Wesley Burks, Edwin H Kim. Current Insights into Immunotherapy Approaches for Food Allergy. ImmunoTargets and therapy. 2021, 10: 1-8
Cited : 12Read More - 2)- Yang Yang, Md Sahidul Islam, Yuanjia Hu, Xin Chen. TNFR2: Role in Cancer Immunology and Immunotherapy. ImmunoTargets and therapy. 2021, 10: 103-122Cited : 25Read More
- 3)- Ning Xu, Benjamin Tse, Lu Yang, Tiffany C Y Tang, Michelle Haber, Kenneth Micklethwaite, Alla Dolnikov. Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy. ImmunoTargets and therapy. 2021, 10: 123-140Cited : 9Read More
- 4)- Fabiola Atzeni, Antonio Carriero, Laura Boccassini, Salvatore D'Angelo. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and therapy. 2021, 10: 141-153Cited : 23Read More
- 5)- John W Greiner, Y Maurice Morillon, Jeffrey Schlom. NHS-IL12, a Tumor-Targeting Immunocytokine. ImmunoTargets and therapy. 2021, 10: 155-169Cited : 24Read More
- 6)- Joshua F E Koenig, Kelly Bruton, Allyssa Phelps, Emily Grydziuszko, Rodrigo Jiménez-Saiz, Manel Jordana. Memory Generation and Re-Activation in Food Allergy. ImmunoTargets and therapy. 2021, 10: 171-184Cited : 15Read More
- 7)- Marco Tagliamento, Elisa Agostinetto, Roberto Borea, Mariana Brandão, Francesca Poggio, Alfredo Addeo, Matteo Lambertini. VISTA: A Promising Target for Cancer Immunotherapy? ImmunoTargets and therapy. 2021, 10: 185-200Cited : 39Read More
- 8)- Hamza Hashmi, Muhammad Husnain, Ali Khan, Saad Z Usmani. CD38-Directed Therapies for Management of Multiple Myeloma. ImmunoTargets and therapy. 2021, 10: 201-211Cited : 9Read More
- 9)- Fumio Takaiwa. Next-Generation Allergen-Specific Immunotherapy for Japanese Cedar Pollinosis Using Molecular Approaches. ImmunoTargets and therapy. 2021, 10: 213-224Cited : 3Read More
- 10)- Nikesh N Shah, Lubomir Sokol. Targeting CD22 for the Treatment of B-Cell Malignancies. ImmunoTargets and therapy. 2021, 10: 225-236Cited : 33Read More
- 11)- Kaja Kasarello, Dagmara Mirowska-Guzel. Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era. ImmunoTargets and therapy. 2021, 10: 237-246Cited : 7Read More
- 12)- Mika Casey, Kyohei Nakamura. The Cancer-Immunity Cycle in Multiple Myeloma. ImmunoTargets and therapy. 2021, 10: 247-260Cited : 14Read More
- 13)- Valeria Giorgi, Daniela Marotto, Alberto Batticciotto, Fabiola Atzeni, Sara Bongiovanni, Piercarlo Sarzi-Puttini. Cannabis and Autoimmunity: Possible Mechanisms of Action. ImmunoTargets and therapy. 2021, 10: 261-271Cited : 16Read More
- 14)- Bettina Wedi, Stephan Traidl. Anti-IgE for the Treatment of Chronic Urticaria. ImmunoTargets and therapy. 2021, 10: 27-45Cited : 24Read More
- 15)- Sofiane Fodil, Djillali Annane. Complement Inhibition and COVID-19: The Story so Far. ImmunoTargets and therapy. 2021, 10: 273-284Cited : 16Read More
- 16)- Sarah Unterberger, Kevin A Davies, Srinivasa Bhargav Rambhatla, Sandra Sacre. Contribution of Toll-Like Receptors and the NLRP3 Inflammasome in Rheumatoid Arthritis Pathophysiology. ImmunoTargets and therapy. 2021, 10: 285-298Cited : 20Read More
- 17)- Poonkiat Suchonwanit, Chaninan Kositkuljorn, Cherrin Pomsoong. Alopecia Areata: An Autoimmune Disease of Multiple Players. ImmunoTargets and therapy. 2021, 10: 299-312Cited : 37Read More
- 18)- Reyisa Bughda, Paraskevi Dimou, Reena R D'Souza, Astero Klampatsa. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma. ImmunoTargets and therapy. 2021, 10: 313-323Cited : 78Read More
- 19)- Michael Levy, Maureen A Mealy. B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20. ImmunoTargets and therapy. 2021, 10: 325-331Cited : 6Read More
- 20)- Laura C Arneson, Kristen J Carroll, Eric M Ruderman. Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis. ImmunoTargets and therapy. 2021, 10: 333-342Cited : 23Read More
- 21)- Hanley N Abramson. Immunotherapy of Multiple Myeloma: Promise and Challenges. ImmunoTargets and therapy. 2021, 10: 343-371Cited : 14Read More
- 22)- Angela Gomez-Arboledas, Munjal M Acharya, Andrea J Tenner. The Role of Complement in Synaptic Pruning and Neurodegeneration. ImmunoTargets and therapy. 2021, 10: 373-386Cited : 84Read More
- 23)- Surojit Karmakar, Pradipta Pal, Girdhari Lal. Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. ImmunoTargets and therapy. 2021, 10: 387-407Cited : 13Read More
- 24)- Megan Mosca, Julie Hong, Edward Hadeler, Marwa Hakimi, Wilson Liao, Tina Bhutani. The Role of IL-17 Cytokines in Psoriasis. ImmunoTargets and therapy. 2021, 10: 409-418Cited : 39Read More
- 25)- Bárbara Kong-Cardoso, Amélia Ribeiro, Rita Aguiar, Helena Pité, Mário Morais-Almeida. Understanding and Managing Severe Asthma in the Context of COVID-19. ImmunoTargets and therapy. 2021, 10: 419-430Cited : 1Read More
- 26)- Shouling Zhang, Scott Sicherer, M Cecilia Berin, Amanda Agyemang. Pathophysiology of Non-IgE-Mediated Food Allergy. ImmunoTargets and therapy. 2021, 10: 431-446Cited : 36Read More
- 27)- Priscila O Barros, Tamara K Berthoud, Nawaf Aloufi, Jonathan B Angel. Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent. ImmunoTargets and therapy. 2021, 10: 47-62Cited : 8Read More
- 28)- Amal Hasan, Ebaa Al-Ozairi, Zahraa Al-Baqsumi, Rasheed Ahmad, Fahd Al-Mulla. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. ImmunoTargets and therapy. 2021, 10: 63-85Cited : 40Read More
- 29)- Friederike Held, Ana-Katharina Klein, Achim Berthele. Drug Treatment of Neuromyelitis Optica Spectrum Disorders: Out with the Old, in with the New? ImmunoTargets and therapy. 2021, 10: 87-101Cited : 20Read More
- 30)- Francesco Passiglia, Maria Lucia Reale, Valeria Cetoretta, Silvia Novello. Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? ImmunoTargets and therapy. 2021, 10: 9-26Cited : 16Read More
